The Global Medical Plastics Market Continues To Grow Owing To the Increasing Demand from Healthcare Sectors across the Globe to Meet the Requirements of Proper Maintenance of Health and Sanitation
Medical
plastics are any material used in the manufacturing of medical products that
have been through some type of process that leaves behind an element that can
be considered a synthetic element. This can be in the form of solid,
semi-solid, or liquid plastic. One of the most popular of these plastics is
silicone. Silicone is a type of thermoplastic that was created way back in 1960
and since then it has been found to have many positive qualities and
characteristics. The main reason to use medical plastics is because of how
flexible and durable they are. Being flexible allows them to be moved into any
form possible. Although these plastics have many positive qualities they also
have a few negative attributes. One of these negatives is that they have great
resistance towards chemicals, particularly cytotoxic chemicals.
Market Dynamics
The
main driving factors influencing the growth of the medical plastics market are
the increasing technological advancements and rising competition amongst the
key players along with high investments in research and development sectors.
Medical plastics have witnessed increasing growth owing to technological
developments such as multipurpose drug packaging, point-of-care (POC)
instruments, and miniature devices. The development of device barcodes and
Unique Device Identification (UDI) are included in the technological
advancements which are making it easier for medical professionals and the staff
to understand the accurate use and the expiration dates of medical plastics.
Organizations are working hand in hand to create products that can meet the
demand for new technologically equipped products. Moreover, the growing
competition between key players to produce the best product before each other
is anticipated to propel the market growth. Additionally, governments and
private investors across the globe are showing an inclination towards investing
in the R&D sector and is expected to drive the medical plastics market. For
instance, according to the United States Department of Agriculture's Foreign
Agricultural Service, in 2018, federal funding for R&D activities in the
region was approximately US$ 2.8 billion.
However,
environmental concerns and improper management of medical waste are the main
restraining factors hindering the market growth of medical plastic. The
population density of the world is ever-increasing which has resulted in the
demand for plastics. Medical plastic products also have a part in continuous
expansion in plastic production and waste generation that are affecting
industry growth and increasing pollution.
This
market is distributed in five regions that include North America, Europe,
Asia-Pacific, Middle East, and Africa, and Latin America. Among these North
America is estimated to hold a significant share of the medical
plastics market owing to the increased amount of investments in the R&D
sectors and the rapid expansion of the healthcare sector in the region. For
instance, according to the Centers for Medicare & Medicaid Services, the
expenditure on the U.S. health care sector in 2019 was approximately 4.6% reaching
US$ 3.8 trillion, i.e., approximately US$ 11,582 for each individual. Moreover,
the rise of the disposable income groups and changes in consumers' lifestyle is
also estimated to drive the market in this region. The medical plastic market
in the Asia Pacific is estimated to witness significant growth owing to the
rapid demand for sanitation and medical hygiene from consumers.
Competitive
Analysis
Key
players operating in the global medical plastics market include Trinseo,
Ensinger, Lubrizol Corporation, BASF SE, Arkema, and Celanese Corporation.
In
April 2020, Celanese Corporation provided the medical devices and healthcare
industry by providing hygienic medical plastics for applications in equipment
such as ventilators. Respirators and other medical equipment. In October 2019,
Evonik launched the first-ever commercial line of PLA_PEG bioresorbable
copolymers for application in implantable medical devices.

Comments
Post a Comment